Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kanokphon Ritthitham"'
Autor:
Surakameth Mahasirimongkol, Athiwat Khunphon, Oraya Kwangsukstid, Sompong Sapsutthipas, Mingkwan Wichaidit, Archawin Rojanawiwat, Nuanjun Wichuckchinda, Wiroj Puangtubtim, Warangluk Pimpapai, Sakulrat Soonthorncharttrawat, Asawin Wanitchang, Anan Jongkaewwattana, Kanjana Srisutthisamphan, Daraka Phainupong, Naphatcha Thawong, Pundharika Piboonsiri, Waritta Sawaengdee, Thitiporn Somsaard, Kanokphon Ritthitham, Supaporn Chumpol, Nadthanan Pinyosukhee, Rattanawadee Wichajarn, Panadda Dhepakson, Sopon Iamsirithaworn, Supaporn Phumiamorn
Publikováno v:
Vaccines, Vol 10, Iss 4, p 536 (2022)
In response to the SARS-CoV-2 Delta variant, which partially escaped the vaccine-induced immunity provided by two doses of vaccination with CoronaVac (Sinovac), the National Vaccine Committee recommended the heterologous CoronaVac-ChAdOx1 (Oxford–A
Externí odkaz:
https://doaj.org/article/518ddbc5fd4a4ebe97eaf658e10ba8ca
Autor:
Surakameth Mahasirimongkol, Athiwat Khunphon, Oraya Kwangsukstid, Sompong Sapsutthipas, Mingkwan Wichaidit, Archawin Rojanawiwat, Nuanjun Wichuckchinda, Wiroj Puangtubtim, Warangluk Pimpapai, Sakulrat Soonthorncharttrawat, Asawin Wanitchang, Anan Jongkaewwattana, Kanjana Srisutthisamphan, Daraka Phainupong, Naphatcha Thawong, Pundharika Piboonsiri, Waritta Sawaengdee, Thitiporn Somsaard, Kanokphon Ritthitham, Supaporn Chumpol, Nadthanan Pinyosukhee, Rattanawadee Wichajarn, Panadda Dhepakson, Sopon Iamsirithaworn, Supaporn Phumiamorn
Publikováno v:
Vaccines; Volume 10; Issue 4; Pages: 536
In response to the SARS-CoV-2 Delta variant, which partially escaped the vaccine-induced immunity provided by two doses of vaccination with CoronaVac (Sinovac), the National Vaccine Committee recommended the heterologous CoronaVac-ChAdOx1 (Oxford–A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ce2442c79760a2a90768f61ca6df44
https://pubmed.ncbi.nlm.nih.gov/35455285
https://pubmed.ncbi.nlm.nih.gov/35455285
Autor:
Nasikarn Angkasekwinai, Suvimol Niyomnaitham, Jaturong Sewatanon, Supaporn Phumiamorn, Kasama Sukapirom, Sansnee Senawong, Zheng Quan Toh, Pinklow Umrod, Thitiporn Somporn, Supaporn Chumpol, Kanokphon Ritthitham, Yuparat Jantraphakorn, Kanjana Srisutthisamphan, Kulkanya Chokephaibulkit
The CoronaVac (Sinovac Biotech) and ChAdOx1(Oxford-AstraZeneca) are two widely used COVID-19 vaccines. We examined the immunogenicity of four COVID-19 booster vaccine: BBIBP-CorV (Sinopharm Biotech), ChAdOx1, 30μg-BNT162b2 and 15μg-BNT162b2 (Pfizer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c78a71f0be0bce1f2c255a7efba6e844
https://doi.org/10.1101/2021.11.29.21266947
https://doi.org/10.1101/2021.11.29.21266947
Autor:
Kanjana Srisutthisamphan, Thitiporn Somporn, Kanokphon Ritthitham, Anan Jongkaewwattana, Archawin Rojanawiwat, Sopon Iamsiritahworn, Rattanawadee Wichajarn, Athiwat Khunphon, Daraka Phainupong, Supaporn Phumiamorn, Panadda Dhepaksorn, Pundharika Piboonsiri, Surakameth Mahasirimongkol, Warittha Sawaengdee, Nadthanan Pinyosukhee, Wiroj Puangtubtim, Supaporn Chumpol, Sompong Sapsutthipas, Penpitcha Thawong, Sakulrat Soonthorncharttrawat, Asawin Wanitchang, Warangluk Pimpapai, Oraya Kwangsukstid, Nuanjun Wichuckchinda, Minkwan Wichaidit
BackgroundResponding to SARS-CoV-2 Delta variants escaped the vaccine-induced immunity and waning immunity from the inactivated whole virus vaccine, Thailand recently proposed a heterologous inactivated whole virus vaccine (CoronaVac) viral vector va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ce5d6ad79e7e46dcad713d1b92564bc
https://doi.org/10.1101/2021.11.05.21264700
https://doi.org/10.1101/2021.11.05.21264700